Quest Diagnostics' Q4 Revenues Slide 4 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Quest Diagnostics today reported a 4 percent drop year over year in fourth-quarter sales as Hurricane Sandy shrank revenues by $21 million.

For the three months ended Dec. 31, 2012, revenues totaled $1.77 billion, down from $1.85 billion a year ago and short of the consensus Wall Street estimate of $1.80 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.